Log in | Register

Understanding thrombotic microangiopathies in children

Bérangère S. Joly| X. Long Zheng| Agnès Veyradier
Understanding the Disease
Volume 44, Issue 9 / September , 2018

Pages 1536 - 1538

No abstract available.

References

  1. George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666
    • View reference on publisher's website
    • View reference on PubMed
  2. George JN, Al-Nouri ZL (2012) Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Am Soc Hematol Educ Progr 2012:604–609
  3. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600
    • View reference on publisher's website
    • View reference on PubMed
  4. Scully M, Cataland S, Coppo P et al (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15:312–322
    • View reference on publisher's website
    • View reference on PubMed
  5. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676–1687
    • View reference on publisher's website
    • View reference on PubMed
  6. Fakhouri F, Zuber J, Frémeaux-Bacchi V et al (2017) Haemolytic uraemic syndrome. Lancet 390:681–696
    • View reference on publisher's website
    • View reference on PubMed
  7. Grangé S, Bekri S, Artaud-Macari E et al (2015) Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency. Lancet 386:1011–1012
    • View reference on publisher's website
    • View reference on PubMed
  8. Zuber J, Fakhouri F, Roumenina LT et al (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643–657
    • View reference on publisher's website
    • View reference on PubMed
  9. Licht C, Ardissino G, Ariceta G et al (2015) The global aHUS registry: methodology and initial patient characteristics. BMC Nephrol 16:207
    • View reference on publisher's website
    • View reference on PubMed
  10. Noris M, Caprioli J, Bresin E et al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844–1859
    • View reference on publisher's website
    • View reference on PubMed
  11. Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129:2836–2846
    • View reference on publisher's website
    • View reference on PubMed
  12. Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapies. J Thromb Haemost 15:1889–1900
    • View reference on publisher's website
    • View reference on PubMed
  13. Furlan M, Robles R, Galbusera M et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578–1584
    • View reference on publisher's website
    • View reference on PubMed
  14. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594
    • View reference on publisher's website
    • View reference on PubMed
  15. Levy GG, Nichols WC, Lian EC et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488–494
    • View reference on publisher's website
    • View reference on PubMed
  16. Joly BS, Stepanian A, Leblanc T et al (2016) Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Lancet Haematol 3:e537–e546
    • View reference on publisher's website
    • View reference on PubMed
  17. Reese JA, Muthurajah DS, Kremer Hovinga JA et al (2013) Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 60:1676–1682
    • View reference on publisher's website
    • View reference on PubMed
  18. Joly BS, Vanhoorelbeke K, Veyradier A (2017) Understanding therapeutic targets in thrombotic thrombocytopenic purpura. Intensive Care Med. https://doi.org/10.1007/s00134-016-4662-3
    • View reference on PubMed
  19. Scully M, Knöbl P, Kentouche K et al (2017) Recombinant human ADAMTS-13: first in human study evaluating pharmacokinetics, safety and tolerability in cTTP patients. Blood 130:2055–2063
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement